Editorial
doi: 10.1016/j.sleep.2010.01.003.
Epub 2010 Apr 3.
Finding a safe and effective intravenous iron treatment for restless legs syndrome
- PMID: 20371211
- DOI: 10.1016/j.sleep.2010.01.003
Item in Clipboard
Editorial
Finding a safe and effective intravenous iron treatment for restless legs syndrome
Sleep Med.
2010 May.
No abstract available
Comment on
-
Intravenous iron dextran for severe refractory restless legs syndrome.Sleep Med. 2010 May;11(5):494-6. doi: 10.1016/j.sleep.2009.12.002. Epub 2010 Apr 3. Sleep Med. 2010. PMID: 20371212
Similar articles
-
Intravenous iron dextran for severe refractory restless legs syndrome.Sleep Med. 2010 May;11(5):494-6. doi: 10.1016/j.sleep.2009.12.002. Epub 2010 Apr 3. Sleep Med. 2010. PMID: 20371212
-
Lower molecular weight intravenous iron dextran for restless legs syndrome.Sleep Med. 2013 Mar;14(3):274-7. doi: 10.1016/j.sleep.2012.11.001. Epub 2013 Jan 18. Sleep Med. 2013. PMID: 23333678 Clinical Trial.
-
Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.Int J Clin Pract. 2008 Mar;62(3):413-5. doi: 10.1111/j.1742-1241.2007.01401.x. Epub 2007 Nov 12. Int J Clin Pract. 2008. PMID: 18005041
-
Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease.Kidney Int. 2008 Mar;73(5):528-30. doi: 10.1038/sj.ki.5002779. Kidney Int. 2008. PMID: 18274543 Review.
-
Intravenous iron therapy: well-tolerated, yet not harmless.Eur J Clin Invest. 2005 Dec;35 Suppl 3:46-51. doi: 10.1111/j.1365-2362.2005.01530.x. Eur J Clin Invest. 2005. PMID: 16281958 Review.
Cited by
-
Strategies for the treatment of restless legs syndrome.Neurotherapeutics. 2012 Oct;9(4):776-90. doi: 10.1007/s13311-012-0139-4. Neurotherapeutics. 2012. PMID: 22923001 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
